DAX23.931 -0,3%ESt505.356 -0,2%Top 10 Crypto13,90 -2,0%Dow42.305 +0,1%Nas19.243 +0,7%Bitcoin92.870 +0,4%Euro1,1440 ±-0,0%Öl65,03 -0,1%Gold3.374 -0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 RENK RENK73 HENSOLDT HAG000 NVIDIA 918422 BioNTech (ADRs) A2PSR2 Tesla A1CX3T Siemens Energy ENER6Y BYD A0M4W9 Gerresheimer A0LD6E Lufthansa 823212 thyssenkrupp 750000 Bayer BAY001 BASF BASF11 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Bank 514000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Zollchaos: DAX schließt tiefer -- US-Handel endet höher -- Trump will Stahlzölle verdoppeln -- DHL erhöht Preise für Privat-Pakete -- Tesla, Infineon, Rheinmetall, RENK, Siemens Energy im Fokus
Top News
UBS rät zum Verkauf der Tesla-Aktie: Diese Faktoren gefährden das Wachstum UBS rät zum Verkauf der Tesla-Aktie: Diese Faktoren gefährden das Wachstum
Google-Studie: Quantencomputer bedrohen RSA- und Bitcoin-Verschlüsselung früher als gedacht Google-Studie: Quantencomputer bedrohen RSA- und Bitcoin-Verschlüsselung früher als gedacht
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Enochian Biosciences Aktie

Handeln
Aktien-Sparplan anlegen
0,2460 EUR -0,0180 EUR -6,82 %
STU
0,2899 USD -0,0200 USD -6,45 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.46,58 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PBYQ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS29350E1047

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolRENB

Enochian Biosciences Aktien News

DatumMeistgelesen
GlobeNewswireRenovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
GlobeNewswireRenovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
GlobeNewswireRenovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
GlobeNewswireAI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer
GlobeNewswireEnochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting
GlobeNewswireEnochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review
GlobeNewswireEnochian BioSciences’ CEO Letter to Shareholders
GlobeNewswireEnochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher
GlobeNewswireEnochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
GlobeNewswireEnochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022
GlobeNewswireEnochian BioSciences Forges Ahead With Focused Approach, Promising Future
GlobeNewswireEnochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K
GlobeNewswireEnochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform
PR NewswireENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022
PR NewswireENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022
PR NewswireENOB LAWSUIT ALERT: Levi & Korsinsky Notifies Enochian BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Action Filed on Behalf of Enochian BioSciences, Inc. Shareholders
PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Enochian Investors of a Lead Plaintiff Deadline of September 26, 2022
PR NewswireENOB Investors Have Opportunity to Lead Enochian Biosciences, Inc. Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Enochian BioSciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2022 - (NASDAQ: ENOB)
PR NewswireENOCHIAN BIOSCIENCES, INC. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the...
PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Enochian Investors of a Lead Plaintiff Deadline of September 26, 2022
PR NewswireENOB Investors Have Opportunity to Lead Enochian Biosciences, Inc. Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Enochian BioSciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2022 - (NASDAQ: ENOB)
PR NewswireENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022
PR NewswireENOCHIAN BIOSCIENCES, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the...
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Enochian BioSciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2022 - (NASDAQ: ENOB)
PR NewswireENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Action Filed on Behalf of Enochian BioSciences, Inc. Shareholders
PR NewswireSHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - ENOB
PR NewswireENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022
PR NewswireENOCHIAN BIOSCIENCES, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the...
PR NewswireBronstein, Gewirtz & Grossman, LLC Notifies Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm
GlobeNewswireEnochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor
GlobeNewswireEnochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enochian Biosciences, Inc. - ENOB
Wer­bung

Enochian Biosciences News

Enochian Biosciences News: auf dieser Seite finden Sie alle Enochian Biosciences News und Nachrichten zur Enochian Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Enochian Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Enochian Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.